CDC data shows most Americans fall short on omega-3s

A new CDC report says 98% of Americans are not getting enough EPA and DHA, the omega-3s tied to heart and brain health. Zinzino is using the finding to push its test-based nutrition model, which measures fatty acid levels before and after supplementation.

Why it matters: - The CDC report highlights a broad nutrition gap that affects heart and brain health. - EPA and DHA levels vary by diet, supplementation, lifestyle and biology, so a one-size-fits-all approach can miss the mark. - Zinzino is positioning test-based nutrition as a measurable alternative to guesswork.

What happened: - The U.S. Centers for Disease Control and Prevention found that 98% of the U.S. population are not getting enough EPA and DHA. - The finding appears in the CDC’s 2026 Nutrition Report, using data from the National Health and Nutrition Examination Survey. - Zinzino, a Scandinavian life science company, said the report reinforces its “Test, Don’t Guess” nutrition strategy. - The company is promoting its Balance Concept as a way to assess omega-3 status through at-home testing.

The details: - Zinzino’s BalanceTest uses a finger-prick blood sample to generate a fatty acid profile with six wellness markers. - The test includes the Omega-3 Index and the Omega-6:3 Ratio. - The Omega-3 Index measures blood levels of EPA and DHA. - The Omega-6:3 Ratio measures the balance between omega-6 and omega-3 fatty acids. - Zinzino says the test gives consumers a baseline they can track over time. - The company recommends a follow-up BalanceTest after 120 days. - Zinzino says the before-and-after process helps consumers see how diet, supplementation and lifestyle changes affect their fatty acid profile. - Zinzino’s BalanceOil+ contains EPA and DHA from wild-caught fatty fish plus extra virgin olive oil with naturally occurring antioxidants. - The fish oil is manufactured in Iceland, Friend of the Sea certified and sourced from sardines, mackerel and anchovies. - Zinzino says the product is refined and third-party tested for freshness, safety and purity. - Zinzino says its global fatty acid database includes more than 762,000 blood samples. - In that analysis, people who used the Balance Concept for at least 120 days showed higher omega-3 levels and a more balanced omega-6:3 ratio than non-users and people taking omega-3 supplements on their own. - A company-linked link to the research was referenced in the release as “the findings, linked here.”

Between the lines: - The release uses the CDC data to argue that supplement choice alone is not enough if consumers cannot verify whether blood levels are changing. - Zinzino is trying to shift the conversation from buying omega-3 products to measuring outcomes. - The company’s framing reflects a broader push toward personalized wellness backed by data rather than self-reporting.

What's next: - Zinzino is directing consumers to retest after 120 days to compare results. - The company is encouraging consumers to use test results to guide changes in diet and supplementation. - More information is available at Zinzino’s website.

The bottom line: - The CDC’s omega-3 findings give Zinzino a timely case for its core message: test first, then tailor nutrition to the result.